Search

Tiludronic acid

[A1923] Tiludronic acid was first described in the literature in 1988 as a potential treatment for Paget's disease of bone.[A202235] Tiludronic acid was granted FDA approval on 7 March 1997.[L4763]

Tiratricol

[A274073] Tiratricol is currently being investigated in US clinical trials.

Tafenoquine

[A35671, A35690] It was discovered by the scientists at the Walter Reed Army Institute of Research in 1978 as a substitute for primaquine that would be more effective against relapsing vivax malaria.

Sus scrofa placenta

Sus scrofa placenta is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

5-Hydroxymethylfurfural

Aes-103 has been used in trials studying the treatment and prevention of Hypoxia, Anemia, Sickle Cell, and Sickle Cell Disease.

Curcuma aromatica root oil

The wild ginger has been used as a cosmetic herbal where its rhizomes exhibit a distinct fragrance and color.

Brensocatib

[A274348] Brensocatib was approved by the US FDA on August 12, 2025, for use in adults and pediatric patients with NCFB.[L53808,L53813]

Esterified estrogens

Esterified estrogens are a man-made mixture of estrogens that are used to treat symptoms of menopause such as hot flashes, vaginal dryness, vaginal burning or irritation, or other hormonal changes in the

Drostanolone propionate

Virus Specific T-Cell

Antigens identified as an immune target are presented by antigen-presenting cells (APCs) to T-cells along with other molecules that stimulate their growth and activation.